Blog

Root causes of delays to access and unavailability of innovative medicines, have been identified by the European Federation of Pharmaceutical Industries and Associations (EFPIA):1 I. The time prior to marketing authorisation; II. The price and reimbursement process; III. The value assessment process; IV. Healthcare system constraints and resources; V. The sub-national approval process. Leaning into … Continued

Leaning into the root causes of delays to access (healthcare system constraints and the subnational approval process), we believe the solution lies in healthcare system thinking and subnational access methodologies. Our first principle of subnational access is that if patients are unable to reach the place in the care pathway or the clinic in the … Continued

Critical issues have emerged across healthcare systems, with the focus of health equity and health inequalities being of the highest priority. Health inequalities result in increased morbidity, decreased life expectancy and result in unwarranted variation across systems. THE IMPORTANCE OF HEALTH EQUITY AND TACKLING HEALTH INEQUALITIES Health equity is the most important factor in addressing … Continued